We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MANT
76
DELISTED
Mantech International Corp
MANT
| $3.29M | 0.31% |
+108,997
| New | +$3.15M |
|
|
IPXL
77
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.29M | 0.31% |
+103,843
| New | +$3.04M |
|
78
The Ensign Group
ENSG
$10.1B
| $3.24M | 0.31% |
156,157
-215,331
| -58% | -$3.94M |
|
79
MiMedx Group
MDXG
$626M
| $3.24M | 0.31% |
280,736
+205,720
| +274% | +$2.03M |
|
|
ARUN
80
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $3.21M | 0.31% |
+176,681
| New | +$3.52M |
|
|
SIGM
81
DELISTED
Sigma Designs Inc
SIGM
| $3.21M | 0.31% |
433,776
+123,601
| +40% | +$555K |
|
82
DHI Group
DHX
$166M
| $3.2M | 0.31% |
319,739
-218,330
| -41% | -$2.15M |
|
|
SNBR
83
DELISTED
Sleep Number
SNBR
| $3.2M | 0.31% |
118,308
+77,257
| +188% | +$1.92M |
|
|
FRGI
84
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $3.16M | 0.3% |
+51,932
| New | +$2.86M |
|
|
HSII
85
DELISTED
Heidrick & Struggles
HSII
| $3.12M | 0.3% |
135,349
-39,411
| -23% | -$825K |
|
|
SGNT
86
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $3.12M | 0.3% |
124,076
-16,451
| -12% | -$483K |
|
|
CTIC
87
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.06M | 0.29% |
+129,574
| New | +$3M |
|
88
Moelis & Co
MC
$4.98B
| $3.04M | 0.29% |
+86,896
| New | +$2.87M |
|
89
Comscore
SCOR
| $3.02M | 0.29% |
+3,256
| New | +$2.73M |
|
|
IVC
90
DELISTED
Invacare Corporation
IVC
| $3.02M | 0.29% |
180,221
+116,349
| +182% | +$1.77M |
|
91
Rogers Corp
ROG
$2.33B
| $3.02M | 0.29% |
+37,036
| New | +$2.47M |
|
92
Taylor Morrison
TMHC
| $3M | 0.29% |
+159,036
| New | +$2.84M |
|
|
BGC
93
DELISTED
General Cable Corporation
BGC
| $2.98M | 0.28% |
+199,762
| New | +$2.79M |
|
94
Boyd Gaming
BYD
$6.47B
| $2.94M | 0.28% |
229,658
-174,919
| -43% | -$1.97M |
|
95
Zurn Elkay Water Solutions
ZWS
$8.07B
| $2.93M | 0.28% |
215,642
+163,121
| +311% | +$2.15M |
|
96
Merit Medical Systems
MMSI
$4.43B
| $2.93M | 0.28% |
168,956
+493
| +0.3% | +$7.29K |
|
|
VG
97
DELISTED
Vonage Holdings Corporation
VG
| $2.9M | 0.28% |
761,461
-401,802
| -35% | -$1.38M |
|
|
LABL
98
DELISTED
Multi-Color Corp
LABL
| $2.9M | 0.28% |
52,335
-37,357
| -42% | -$1.92M |
|
|
MGLN
99
DELISTED
Magellan Health Services, Inc.
MGLN
| $2.9M | 0.28% |
48,235
-54,227
| -53% | -$3.2M |
|
|
MASI
100
DELISTED
Masimo
MASI
| $2.88M | 0.27% |
109,250
+34,134
| +45% | +$842K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.